4
Changes in Ownership
Atea Pharmaceuticals, Inc. Filed Acc 0000950170-25-013844
EVP, Chief Accounting Officer gave up 12,062 shares (to pay taxes)
- EVP, Chief Accounting Officer acquired 8,000 shares (grant or award)
- EVP, Chief Accounting Officer acquired 33,333 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Foster Wayne EVP, Chief Accounting Officer | 2025-01-31 | Option exercise | +33,333 | 54,190 | D | ||
| Foster Wayne EVP, Chief Accounting Officer | 2025-01-31 | Grant or award | +8,000 | 62,190 | D | ||
| Foster Wayne EVP, Chief Accounting Officer | 2025-01-31 | Shares withheld for taxes | −12,062 | $3.06 | $36,910 | 50,128 | D |
| Derivatives | |||||||
| Foster Wayne EVP, Chief Accounting Officer | 2025-01-31 | Option exercise · Restricted Stock Units | −33,333 | 33,333 | D | ||
| Foster Wayne EVP, Chief Accounting Officer | 2025-01-31 | Grant or award · Restricted Stock Units | +8,000 | 8,000 | D | ||
| Foster Wayne EVP, Chief Accounting Officer | 2025-01-31 | Grant or award · Stock Option (Right to Buy) | +120,100 | 120,100 | D | ||
Loading xslF345X05/ownership.xml…